scispace - formally typeset
S

Shintaro Kinugawa

Researcher at Hokkaido University

Publications -  202
Citations -  9872

Shintaro Kinugawa is an academic researcher from Hokkaido University. The author has contributed to research in topics: Heart failure & Skeletal muscle. The author has an hindex of 46, co-authored 189 publications receiving 8369 citations. Previous affiliations of Shintaro Kinugawa include Kyushu University & Hokkaido University of Education.

Papers
More filters
Journal ArticleDOI

Oxidative stress and heart failure

TL;DR: Oxidative stress is involved in the pathophysiology of HF in the heart as well as in the skeletal muscle, and a better understanding of these mechanisms may enable the development of novel and effective therapeutic strategies against HF.
Journal ArticleDOI

Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium

TL;DR: Direct evidence is provided for the involvement of ROS in the mitochondrial origin of HF myocytes, which might be responsible for both contractile dysfunction and structural damage to the myocardium.
Journal ArticleDOI

Direct Evidence for Increased Hydroxyl Radicals Originating From Superoxide in the Failing Myocardium

TL;DR: There was a significant positive relation between myocardial ROS level and left ventricular contractile dysfunction and, in the failing myocardium, *OH was produced as a reactive product of *O(2)(-) and H(2)O( 2), which might play an important role inleft ventricular failure.
Journal ArticleDOI

JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―

Hiroyuki Tsutsui, +61 more
- 25 Sep 2019 - 
TL;DR: This English language document is a revised digest version of Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure (JCS 2017/JHFS 2017) reported at the Japanese Circulation Society Joint Working Groups performed in 2017.
Journal Article

Oxidative stress and heart failure

TL;DR: The regulation of mitochondrial oxidative stress or manipulation of TFAM protein may provide a novel therapeutic strategy of HF.